Anal Squamous Cell Carcinoma, Limited-stage
1 clinical trials · Condition
◉ Watch Anal Squamous Cell Carcinoma, Limited-stage
| Record | Firm | Date |
|---|---|---|
| Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma (NCT07692152) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-03-17 |
Track Anal Squamous Cell Carcinoma, Limited-stage automatically
Every clearance here is in the API, with alerts when new ones post.